解读C3a无线毒素的作用:调节瘤微环境的关键功能
Jolimar Hanna1,2, Franck Ah-Pine1,3, Chailas Boina1,2
1Unité de Recherche EPI (Études Pharmaco-Immunologiques), Université de La Réunion, Allée des Topazes, 97405 Saint-Denis, France.
Cancers
|June 10, 2023
概括
补充系统是补充系统.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 补体系统是癌症发展的组成部分.
- 在瘤微环境 (TME) 中C3a过敏毒素的特定作用需要进一步阐明.
- 了解这些相互作用是开发新型癌症疗法的关键.
研究的目的:
- 为了研究C3a过敏毒素对瘤微环境的影响.
- 分析C3a对TME中介质干细胞 (MSC) 和巨细胞的影响.
- 探索C3a对细胞因子表达,抗氧化机制和血管生成的影响.
主要方法:
- 使用了类似于介质干细胞 (3T3-L1) 的细胞模型,巨细胞 (Raw 264.7 Blue) 和黑色素瘤细胞模型 (B16/F0).
- 使用CHO细胞表达系统制造的复合老鼠C3a (rC3a).
- 在接受rC3a,IFN-γ,TGF-β1和LPS治疗后,评估了关键分子 (C3,C3aR,PI3K),细胞因子,化学因子和M1/M2巨分极标记物的表达.
主要成果:
- 介酶干细胞 (3T3-L1) 显示出高C3表达,而巨细胞 (RB) 则表达出更多的C3aR;两者都受到IFN-γ的上调.
- rC3a在3T3-L1细胞中诱导IL-10,在RB细胞中诱导TGF-β1和促炎细胞因子.
- 在巨细胞中,rC3a上调抗氧化基因 (HO-1) 和VEGF,这表明在TME中具有益血管性和抗炎作用.
结论:
- 由MSCs产生的C3/C3a显著影响瘤微环境.
- 在瘤 stromal 细胞内,C3a 促进了抗炎和益血管性活动.
- 这些发现凸显了C3a作为癌症治疗中的潜在治疗点.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.6K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
